Skip to content
  • Home
Menu
  • Home
Login

Competition and Markets Authority

  1. Home>
  2. Arts>
  3. Competition and Markets Authority>
  4. Page 16

CMA letter to Somerset Bridge Group about a breach of the Private Motor Insurance Order

  • Post author:
  • Post published:19/12/2024
  • Post category:

Somerset Bridge Group Limited breached Part 2 of the Order by failing to provide the correct price of No Claims Bonus Protection to some customers, and by failing to provide…

Continue ReadingCMA letter to Somerset Bridge Group about a breach of the Private Motor Insurance Order

Unfair commercial practices guidance

  • Post author:
  • Post published:12/12/2024
  • Post category:

Unfair commercial practices CMA207con Consultation on draft guidance on the protection from unfair trading provisions in the Digital Markets, Competition and Consumers Act 2024 11 December 2024 © Crown copyright…

Continue ReadingUnfair commercial practices guidance

Consumer protection: enforcement guidance

  • Post author:
  • Post published:12/12/2024
  • Post category:

The CMA has produced draft guidance on its role and powers related to consumer protection. The draft guidance updates and, once finalised, will replace the existing guidance.The draft guidance provides…

Continue ReadingConsumer protection: enforcement guidance

CMA probes possible bid-rigging in relation to school improvement fund

  • Post author:
  • Post published:12/12/2024
  • Post category:

Unannounced inspections have been carried out at several business premises, to gather evidenceThe Competition and Markets Authority (CMA) has reason to suspect that several companies providing roofing and construction services…

Continue ReadingCMA probes possible bid-rigging in relation to school improvement fund

Consultation on proposed commitments in respect of Vifor Pharma’s supply of intravenous iron

  • Post author:
  • Post published:11/12/2024
  • Post category:

The Competition and Markets Authority (CMA) invites views on commitments offered by Vifor Pharma, in relation to our investigation into its conduct in the market for the supply of high-dose…

Continue ReadingConsultation on proposed commitments in respect of Vifor Pharma’s supply of intravenous iron
  • Go to the previous page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 66
  • Go to the next page
  • Become an employer
    • Post Your Job
    • Business Account
    • Resource Center
    • Community
Copyright - OceanWP Theme by OceanWP

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Click here

Enter your Email

Enter your registered username/email id.

Verify OTP

An OTP has been sent to your registered email address.

Enter your Email

Enter your email id below to signup.

Verify Email

Enter the 4-digit OTP shared on your email

Edit

Tell us more about yourself

Enter your name and organization

Select your work area

This will helps us to provide you with better personalisation and experience

Select your country

This will helps us to provide you with better personalisation and experience

All set.

Welcome, ! Your GRI account has been successfully set up.
Visit Dashboard
Individual Plan
  • Designed for Growing Compliance Teams
$125 / month OR $1250 / year
Features
  • • Coverage for 20 jurisdictions
  • • Monitoring from 500+ regulatory authorities
  • • AI compliance summaries
  • • RaDa.ai : Single-Role
Best for: Researchers, Legal professionals, Academics
Subscribe Now
Enterprise Plan
  • Perfect for Global Enterprises
Contact for Pricing
Features
  • • Custom jurisdictional coverage
  • • Custom monitoring of regulatory authorities
  • • RaDa.ai : Customizable multi-role
  • • Custom reporting and dashboard capabilities
  • • API access for seamless integration
Best for: Law Firms, Corporations, Government Bodies
Contact Sales